@misc{indiciae65a08f0550a9,
  title = {Galectin-3 as a new negative checkpoint of the immune response is the key target for effective immunotherapy against prostate cancer},
  author = {Tiraboschi, C. and Gentilini, L. and Corapi, E. and Jaworski, F. M. and Velazquez, C. and Chauchereau, A. and Laderach, D. J. and Compagno, D.},
  year = {2019},
  doi = {10.1101/763409},
  url = {https://www.biorxiv.org/content/10.1101/763409v1},
  note = {Source identifier: 10.1101/763409}
}